SB Drug Discovery

SB Drug Discovery News

Vacancies (25th July, 2017)

Electrophysiologists

As a result of the increased business, SB Drug Discovery has openings for part time and full time electrophysiologists with proven laboratory experience. The successful candidates will be responsible for a broad range of challenging tasks including validation of new ion channel targets, assay development and contract research.  An ability to perform single cell electrophysiology and analyse data is essential. Mammalian cell culture experience and / or experience of automated electrophysiology platforms would also be advantageous however not essential as relevant training will be provided. Suitable applicants will have strong organisation and communication skills and will demonstrate ability to work with accuracy in a team environment. In return, you will become a key member of a dynamic team of experienced scientists at the forefront of ion channel contract research. Flexible working conditions are offered along with a competitive salary and benefits.

Full CV and covering letter should be sent to enquiries@sbdrugdiscovery.com 

SB Drug Discovery - July 2017


Ion Channel Modulation Symposium

SB Drug Discovery is pleased to sponsor the 2017 Ion Channel Modulation Symposium, 21/22 June at Clare College, Cambridge. The symposium will bring together leading international researchers from academia and industry to share their latest advances and discuss current, cutting edge research focused on the modulation of this important class of receptors as therapeutic targets.

SB Drug Discovery - May 2017


Sustainable Biosources of Plant Natural Products

SB Drug Discovery is a member of a multidisciplinary European Commission project consortium (DISCO, http://disco-fp7.eu) which includes leading academic experts from plant genetics, molecular biology and metabolic engineering as well as industrial partners. The consortium's focus is on understanding plant biosynthetic pathways involved in the formation of high-value plant products and developing new tools for metabolic engineering and molecular breeding with the ultimate aim to generate new biosources of bioactive and industrial phytochemicals.

SB Drug Discovery - September 2016


Ion Channel Modulation Symposium

SB Drug Discovery is pleased to sponsor the 2016 Ion Channel Modulation Symposium, 16/17th June at Clare College, Cambridge. The symposium will bring together leading international researchers from academia and industry to share their latest advances and discuss current, cutting edge research focused on the modulation of this important class of receptors as therapeutic targets.

SB Drug Discovery - May 2016


SK Channels in Neuropsychiatric Research Collaboration

SB Drug Discovery's new calcium-activated potassium channel cell lines, SK1, SK2 and SK3 are to be used by scientists from the Centre for Addiction and Mental Health (CAMH) and the University of Toronto, in collaboration with Evotec, in a project aimed at identifying  novel targets for neuropsychiatric disorders.

SB Drug Discovery - May 2016